platinum has been researched along with folic acid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Teow, Y; Valiyaveettil, S | 1 |
| Bronich, TK; Cohen, SM; Kabanov, AV; Nukolova, NV; Oberoi, HS | 1 |
| Mironava, T; Rafailovich, MH; Rigas, B; Simon, M | 1 |
| Burger, RA; Coleman, RL; Depasquale, SE; Gabrail, NY; Gersh, RH; Ghamande, SA; Gilbert, L; Harb, WA; Konstantinopoulos, PA; Kutarska, E; Leamon, CP; Lovejoy, CD; Messmann, RA; Morgenstern, DE; Naumann, RW; Nowara, E; Penson, RT; Sausville, EA; Symanowski, JT; Teneriello, MG | 1 |
| Boase, NR; Eliezar, J; Scarano, W; Stenzel, MH; Thurecht, KJ | 1 |
| Bakandritsos, A; Brabec, V; Kasparkova, J; Medříková, Z; Novohradsky, V; Petr, M; Vrána, O; Zajac, J; Zbořil, R | 1 |
| Bloomfield, A; Cristescu, R; Dorton, R; Dussault, I; Guertin, AD; Haines, BB; Hinton, MC; Leamon, CP; Lejnine, S; Loboda, A; Nebozhyn, M; Nelson, M; O'Neil, J; Picard, KL; Reddy, JA; Schmidt, EV; Stoeck, A; Vetzel, M; Zhang, T | 1 |
| Alnatsha, A; Calleja-Hernández, MÁ; Cañadas-Garre, M; Faus-Dáder, MJ; Pérez-Ramírez, C; Valdivia-Bautista, J; Villar, E | 1 |
| Deng, J; Guo, D; Wu, F; Yang, L; Yang, M; Zhang, J | 1 |
| Cui, P; Dai, Z; Hu, Z; Liu, Q; Yang, B; Yao, X; Zhang, D; Zheng, X | 1 |
| Cui, Y; Hu, X; Kuang, W; Li, C; Ling, X; Ren, J; Sun, X; Yan, Y; Zou, J | 1 |
| Hai, J; Li, T; Li, X; Lu, S; Mu, X; Sun, S; Wang, B; Zhao, Y | 1 |
| Hu, C; Luo, L; Shen, S; Wei, G; Wu, A; Zhang, J; Zhu, F | 1 |
| Fu, T; Li, Y; Liu, Y; Long, W; Stang, PJ; Tan, W; Yan, Y; Zhang, P; Zhao, Z; Zhou, Z | 1 |
| Chen, Z; Liu, S; Su, J; Wang, Z; Wu, Y; Xia, H; Yao, Z | 1 |
1 trial(s) available for platinum and folic acid
| Article | Year |
|---|---|
PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.
Topics: Administration, Intravenous; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Female; Folic Acid; Humans; Kaplan-Meier Estimate; Middle Aged; Nausea; Neutropenia; Oligopeptides; Ovarian Neoplasms; Platinum; Polyethylene Glycols; Treatment Outcome; Vinca Alkaloids | 2013 |
14 other study(ies) available for platinum and folic acid
| Article | Year |
|---|---|
Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Carriers; Folic Acid; Humans; Metal Nanoparticles; Microscopy, Confocal; Platinum; Povidone | 2010 |
Folate-decorated nanogels for targeted therapy of ovarian cancer.
Topics: Animals; Antineoplastic Agents; Biological Availability; Body Weight; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; Drug Delivery Systems; Endocytosis; Female; Folic Acid; Humans; Hydrogels; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Light; Mice; Mice, Nude; Microscopy, Atomic Force; Nanoparticles; Osmolar Concentration; Ovarian Neoplasms; Particle Size; Platinum; Polyethylene Glycols; Polymethacrylic Acids; Scattering, Radiation; Static Electricity; Surface Properties; Survival Analysis; Water; Xenograft Model Antitumor Assays | 2011 |
Platinum folate nanoparticles toxicity: cancer vs. normal cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cells, Cultured; Folic Acid; Humans; Keratinocytes; Metal Nanoparticles; Microscopy, Electron, Transmission; Necrosis; Neoplasms; Platinum | 2013 |
In vivo evaluation of folate decorated cross-linked micelles for the delivery of platinum anticancer drugs.
Topics: Animals; Antineoplastic Agents; Cross-Linking Reagents; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Folic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Platinum | 2015 |
Enhancing Tumor Cell Response to Chemotherapy through the Targeted Delivery of Platinum Drugs Mediated by Highly Stable, Multifunctional Carboxymethylcellulose-Coated Magnetic Nanoparticles.
Topics: Antineoplastic Agents; Carboxymethylcellulose Sodium; Cell Line, Tumor; Cisplatin; Drug Delivery Systems; Folic Acid; Humans; Magnetite Nanoparticles; Platinum | 2016 |
High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Proliferation; Cluster Analysis; Computational Biology; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Folate Receptors, GPI-Anchored; Folic Acid; Gene Expression; Gene Expression Profiling; Humans; Mice; Platinum; RNA, Messenger; Vinca Alkaloids; Xenograft Model Antitumor Assays | 2016 |
Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; DNA Repair; DNA-Binding Proteins; Endonucleases; Female; Folic Acid; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pharmacogenetics; Platinum; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins c-mdm2; Reduced Folate Carrier Protein; Survival Analysis; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein | 2019 |
A folate-conjugated platinum porphyrin complex as a new cancer-targeting photosensitizer for photodynamic therapy.
Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Folic Acid; HeLa Cells; Humans; Molecular Structure; Organoplatinum Compounds; Photochemotherapy; Photosensitizing Agents; Platinum; Porphyrins; Singlet Oxygen; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
Tumor microenvironment responsive FePt/MoS
Topics: Animals; Antineoplastic Agents, Immunological; Folic Acid; HeLa Cells; Humans; Hyperthermia, Induced; Immunotherapy; Iron; MCF-7 Cells; Metal Nanoparticles; Mice; Nanocomposites; Neoplasms, Experimental; Oligodeoxyribonucleotides; Phototherapy; Platinum; Tumor Microenvironment | 2019 |
Novel Cells-Based Electrochemical Sensor for Investigating the Interactions of Cancer Cells with Molecules and Screening Multitarget Anticancer Drugs.
Topics: Aniline Compounds; Antineoplastic Agents; Biosensing Techniques; Chitosan; Dimethyl Sulfoxide; Drug Evaluation, Preclinical; Electrochemical Techniques; Folic Acid; Graphite; Humans; Metal Nanoparticles; Molecular Docking Simulation; Particle Size; Platinum; Surface Properties; Tumor Cells, Cultured | 2021 |
Red-light-responsive coordination polymers nanorods: New strategy for ultrasensitive photothermal detection of targeted cancer cells.
Topics: Biosensing Techniques; Folic Acid; Nanotubes; Neoplasms; Platinum; Polymers | 2021 |
Platinum-Based Nanocomposite Pt@BSA as an Efficient Electrochemical Biosensing Interface for Rapid and Ultrasensitive Determination of Folate Receptor-Positive Tumor Cells.
Topics: Biosensing Techniques; Folic Acid; HeLa Cells; Humans; Nanocomposites; Platinum; Reproducibility of Results | 2022 |
Self-assembled Pt(II) metallacycles enable precise cancer combination chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Liberation; Drug Synergism; Folic Acid; Humans; Mice; Nanoparticles; Neoplasms; Platinum; Polymers; Stilbenes; Tumor Microenvironment | 2022 |
2D Copper(II) Metalated Metal-Organic Framework Nanocomplexes for Dual-enhanced Photodynamic Therapy and Amplified Antitumor Immunity.
Topics: Catalase; Cell Line, Tumor; Copper; Folic Acid; Humans; Hydrogen Peroxide; Metal Nanoparticles; Metal-Organic Frameworks; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Platinum; Reactive Oxygen Species; Tumor Microenvironment | 2022 |